o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
NCT07333976
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer Metastatic Disease
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Neurotoxicity
Interventions
DRUG:
Tadalafil 5 mg
Sponsor
Tri-Service General Hospital